Recurrent T-Cell Non-Hodgkin Lymphoma

13 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Recurrent T-Cell Non-Hodgkin Lymphoma

Record	Firm	Date
Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma (NCT04220008)	M.D. Anderson Cancer Center	2021-10-29
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma (NCT03409432)	John Reneau	2018-03-16
Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03210662)	M.D. Anderson Cancer Center	2018-02-01
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625)	National Cancer Institute (NCI)	2017-09-27
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma (NCT03035331)	Mayo Clinic	2017-08-15
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma (NCT03017820)	Mayo Clinic	2017-04-04
Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies (NCT01921387)	Fred Hutchinson Cancer Center	2013-10-09
Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma (NCT00860171)	Fred Hutchinson Cancer Center	2009-02-01
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00723099)	Fred Hutchinson Cancer Center	2008-06-25

Track Recurrent T-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.